Skip to main content

Typhoid Outbreak in Pakistan Linked to Extensively Drug-Resistant Bacteria

In January, health officials began an aggressive vaccination campaign to counter the spreading disease.

Written byJim Daley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

Color-enhanced scanning electron micrograph of Salmonella Typhimurium (red) invading cultured human cellsWIKIMEDIA, ROCKY MOUNTAIN LABORATORIES, NIAID, NIH

The bacteria behind an ongoing outbreak of typhoid fever in Pakistan is a strain of Salmonella enterica that has become resistant to multiple antibiotic treatments by acquiring new DNA, according to a study reported this week (February 20) in mBio.

More than 300 extensively drug-resistant cases of typhoid have been reported in the provinces surrounding Hyderabad, the city in Pakistan where the outbreak began in November 2016. Researchers at the Wellcome Sanger Institute in the United Kingdom have now discovered that the strain of S. enterica, serovar Typhi (Salmonella Typhi), responsible for the outbreak acquired an additional piece of DNA, or plasmid, that made it resistant to three first-line drugs against the illness—chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole—as well as fluoroquinolones and third-generation cephalosporins.

“Antibiotic resistance has ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo